Exact Mass: 678.3251

Exact Mass Matches: 678.3251

Found 25 metabolites which its exact mass value is equals to given mass value 678.3251, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   
   

4-acetoxy-1beta-(2-methylbutyryloxy)-8,10-epoxyabrotanifolone

4-acetoxy-1beta-(2-methylbutyryloxy)-8,10-epoxyabrotanifolone

C35H50O13 (678.3251)


   

adociasulfate 12

adociasulfate 12

C36H54O8S2 (678.326)


   

briaexcavatin G

briaexcavatin G

C35H50O13 (678.3251)


   

Ile Glu Arg Asp Phe

Ile Glu Arg Asp Phe

C30H46N8O10 (678.3337)


   

IERDF

Ile-Glu-Arg-Asp-Phe

C30H46N8O10 (678.3337)


   

6-O-succinyl methyl ester macrolactin O

7S-(6-O-methyl-succinyl)-beta-D-glucopyranosyl-15-oxo-13S-hydroxy-2Z,4E,8E,10Z,16E,18E,23R-tetracosahexenyl-23-olide

C35H50O13 (678.3251)


   

TRT-CYS(TRT)-OHDEA

TRT-CYS(TRT)-OHDEA

C45H46N2O2S (678.328)


   

meso-Tetrakis(2-N-methylpyridyl)porphine

meso-Tetrakis(2-N-methylpyridyl)porphine

C44H38N8+4 (678.3219)


D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors D000890 - Anti-Infective Agents D003879 - Dermatologic Agents D004791 - Enzyme Inhibitors

   
   
   
   
   

ST 29:5;O7;GlcA

ST 29:5;O7;GlcA

C35H50O13 (678.3251)


   

ST 29:6;O8;Hex

ST 29:6;O8;Hex

C35H50O13 (678.3251)


   

(1s,2s,3s,4r,5s,7s,8r,9r,10s,12z,14s,17r)-2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl 3-methylbutanoate

(1s,2s,3s,4r,5s,7s,8r,9r,10s,12z,14s,17r)-2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl 3-methylbutanoate

C35H50O13 (678.3251)


   

2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl 3-methylbutanoate

2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl 3-methylbutanoate

C35H50O13 (678.3251)


   

(1s,2s,3s,4r,7s,8z,10r,12s,13s,14r,15s)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl (2r)-2-methylbutanoate

(1s,2s,3s,4r,7s,8z,10r,12s,13s,14r,15s)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl (2r)-2-methylbutanoate

C35H50O13 (678.3251)


   

[4-(sulfooxy)-3-({1,2,5-trimethyl-5-[2-(1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl)ethyl]-2,3,6,7,8,8a-hexahydronaphthalen-1-yl}methyl)phenyl]oxidanesulfonic acid

[4-(sulfooxy)-3-({1,2,5-trimethyl-5-[2-(1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl)ethyl]-2,3,6,7,8,8a-hexahydronaphthalen-1-yl}methyl)phenyl]oxidanesulfonic acid

C36H54O8S2 (678.326)


   

(3-{[(1s,2r,5r,8as)-5-{2-[(1s,2s,4ar)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-1,2,5-trimethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-(sulfooxy)phenyl)oxidanesulfonic acid

(3-{[(1s,2r,5r,8as)-5-{2-[(1s,2s,4ar)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-1,2,5-trimethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-(sulfooxy)phenyl)oxidanesulfonic acid

C36H54O8S2 (678.326)


   

2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl 3-methylbutanoate

2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl 3-methylbutanoate

C35H50O13 (678.3251)


   

1-[1-(acetyloxy)ethyl]-3,5-bis[(2-methylbutanoyl)oxy]-7-(2-methyloxiran-2-yl)-2-oxo-hexahydro-1h-spiro[indene-4,2'-oxiran]-6-yl 4-(acetyloxy)-3-methylpent-2-enoate

1-[1-(acetyloxy)ethyl]-3,5-bis[(2-methylbutanoyl)oxy]-7-(2-methyloxiran-2-yl)-2-oxo-hexahydro-1h-spiro[indene-4,2'-oxiran]-6-yl 4-(acetyloxy)-3-methylpent-2-enoate

C35H50O13 (678.3251)


   

(1s,3s,3as,4r,5r,6r,7s,7as)-1-[(1s)-1-(acetyloxy)ethyl]-3,5-bis({[(2r)-2-methylbutanoyl]oxy})-7-[(2s)-2-methyloxiran-2-yl]-2-oxo-hexahydro-1h-spiro[indene-4,2'-oxiran]-6-yl (2e,4s)-4-(acetyloxy)-3-methylpent-2-enoate

(1s,3s,3as,4r,5r,6r,7s,7as)-1-[(1s)-1-(acetyloxy)ethyl]-3,5-bis({[(2r)-2-methylbutanoyl]oxy})-7-[(2s)-2-methyloxiran-2-yl]-2-oxo-hexahydro-1h-spiro[indene-4,2'-oxiran]-6-yl (2e,4s)-4-(acetyloxy)-3-methylpent-2-enoate

C35H50O13 (678.3251)


   

(1r,2r,3r,4s,7r,8z,10s,12r,13r,14s,15r)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl 3-methylbutanoate

(1r,2r,3r,4s,7r,8z,10s,12r,13r,14s,15r)-2,14,15-tris(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-12-[(2-methylpropanoyl)oxy]-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-10-yl 3-methylbutanoate

C35H50O13 (678.3251)